REGENERON PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: 9148477000
CIK: 0000872589
EIN: 133444607
State Location: NY
State of Inc.: NY
Tickers:
  • Nasdaq:REGN

Form: ARS

Filing Date: 24 Apr 2026
Report Date: 31 Dec 2025
Accepted: 24 Apr 2026 02:12 p.m.
Accession Number: 0001104659-26-048580
Act: 34
File Number: 000-19034
Film Number: 26894038

Documents

Primary Document: ARS
Accepted: 24 Apr 2026 02:12 p.m.